- Antimicrobial Catheter Lock System
- Provide Patency and Infection Control
Catheter lock solutions for patients in various contexts.
TauroLock™-U25.000 provides a particularly strong prophylaxis against occlusion, as urokinase serves to break up blood clotting.
- antimicrobial to prevent infections
- antibiofilm to keep catheters clean
- antiocclusive to maintain a good flow rate
TauroLock™-U25.000 has been approved for instillation in all central-venous access systems. This lock solution reliably prevents the formation of bacterial biofilms within catheters. As a result, patients can avoid infections and maintain a high patency rate.
TauroLock™-U25.000 is based on three active ingredients:
citrate (4 %)
urokinase (25,000 units)
Taurolidine has a broad antimicrobial activity (incl. MRSA and VRE), while citrate works as an anticoagulant. At the same time, urokinase yields a thrombolytic effect.
Before applying TauroLock™-U25.000, dissolve the vial’s content (i.e. 25,000 IU urokinase) with 5 ml of TauroLock™. In-between treatment sessions, TauroLock™-U25.000 is instilled into the vascular access system. Please note that medical staff must check the filling volume of the respective catheter or port system.